Deal Insights
Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools
Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools
Learn More
Latest Transactions
.png)
Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools
.png)
Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business
Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network
BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe
.png)
Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
.V3-1.png)
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
%20(1).png)
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
.png)
Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities
%20(NEW).png)
Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally
Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities
Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities
Grant Avenue Capital Recapitalizes CREO
Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform
SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU
What We Do
We empower founders, investors, and operators to confidently connect with leading health sciences companies, align interests, and optimize outcomes.
Investment Banking Services
Strategic Advisory & Origination Services
Recapitalization Services
Investment Banking Services
As a global M&A advisory firm, we're integral to the industries we serve. Our experienced senior bankers, with deep professional relationships and knowledge, deliver services tailored to our core industry focus.
Strategic Advisory & Origination Services
We go beyond value creation. Achieve greater outcomes with our strategic advisory and origination services.
Recapitalization Services
Our deep industry understanding allows us to align growth-oriented companies with financial partners who share a common strategic vision and growth objectives.
Our Focus
Our experienced senior bankers have spent their careers developing deep professional relationships and building in-depth knowledge of the companies, trends and insights relevant to the Health Science industry.
Pharma Services
We cover the entire Pharmaceutical Services industry, from development through commercialization
Learn More
Diagnostics & Tools
Our extensive industry experience spans routine chemistries to the most esoteric of testing
Learn More
Healthcare Technology
We are one of the handful of M&A firms with dedicated coverage to this rapidly shifting area
Featured Insights
Deal Insights
Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business
Actigraph, a Portfolio Company of Archimed, acquired Biofourmis Connect, a Division of Biofourmis, to Establish a Software and Data Ecosystem for Clinical Research Throughout the Drug-product Lifecycle and Across Therapeutic Areas
Learn More
BlueBook
Diagnostics and Tools BlueBook December 2024
Highlights from this edition: Navis Clinical Laboratories was acquired by Wildcat DX, Surgical Science announced its acquisition of Intelligent Ultrasound, Pleno closed a $25 Series A Financing, led by Deerfield Management, Foresite Capital, and Medical Excellence Capital
Download Now
BlueBook
Pharma Services: Pharmaceutical Commerce BlueBook December 2024
Highlights from this edition: Realyze Intelligence was acquired by Carta Healthcare, Kester Capital announced its acquisition of Emas Pharma, Cleerly closed a $298 Series A Financing, led by Battery Ventures, Insight Venture Management, and LRVHealth
Download Now
BlueBook
Pharma Services: Drug Supply Chain BlueBook December 2024
Highlights from this edition: Patterson Companies was acquired by Patient Square Capital, LSL Pharma Group announced its acquisition of Dermolab Pharma, Laurus Labs closed a $14 Series A Financing, led by Eight Roads Ventures and Impresa Management
Download Now
BlueBook
Pharma Services: Drug Development BlueBook December 2024
Highlights from this edition: Insite Clinical Research was acquired by Adams Clinical, Kester Capital announced its acquisition of Emas Pharma, Databricks closed a $10,175MM Series A Financing, led by Insight Venture, Wellington Management, and GIC
Download Now